ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,250.80
      0.45%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.685
      0.18%
      Bitcoin
      62,736.96
      -0.18%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Ferrex (FRX)

      7. Ferrex (FRX) News

      FRX

      Ferrex (FRX)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:FRX
      DateTimeSourceHeadlineSymbolCompany
      12/18/20076:30AMPR Newswire (US)Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of HypertensionNYSE:FRXForest Road Acquisition Corp
      12/13/20074:20PMPR Newswire (US)Forest Laboratories Receives Notification of ANDA Filings for Generic Equivalents of Namenda(R)NYSE:FRXForest Road Acquisition Corp
      12/13/20073:03PMEdgar (US Regulatory)Forest Laboratories Inc - Current report filing (8-K)NYSE:FRXForest Road Acquisition Corp
      12/10/20074:45PMEdgar (US Regulatory)Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4)NYSE:FRXForest Road Acquisition Corp
      12/10/20074:43PMEdgar (US Regulatory)Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4)NYSE:FRXForest Road Acquisition Corp
      12/10/20074:42PMEdgar (US Regulatory)Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4)NYSE:FRXForest Road Acquisition Corp
      12/10/20074:40PMEdgar (US Regulatory)Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4)NYSE:FRXForest Road Acquisition Corp
      12/10/20074:38PMEdgar (US Regulatory)Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4)NYSE:FRXForest Road Acquisition Corp
      12/10/20074:32PMEdgar (US Regulatory)Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4)NYSE:FRXForest Road Acquisition Corp
      12/10/20074:30PMEdgar (US Regulatory)Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4)NYSE:FRXForest Road Acquisition Corp
      12/10/20074:26PMEdgar (US Regulatory)Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4)NYSE:FRXForest Road Acquisition Corp
      12/10/20074:24PMEdgar (US Regulatory)Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4)NYSE:FRXForest Road Acquisition Corp
      12/10/20074:22PMEdgar (US Regulatory)Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4)NYSE:FRXForest Road Acquisition Corp
      12/07/200712:42PMEdgar (US Regulatory)Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4)NYSE:FRXForest Road Acquisition Corp
      12/02/20073:15PMPR Newswire (US)FDA Issues Approvable Letter for Nebivolol for the Treatment of HypertensionNYSE:FRXForest Road Acquisition Corp
      11/29/20079:00AMPR Newswire (US)Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major DepressionNYSE:FRXForest Road Acquisition Corp
      11/09/20074:05PMEdgar (US Regulatory)Forest Laboratories Inc - Quarterly Report (10-Q)NYSE:FRXForest Road Acquisition Corp
      11/09/20074:05PMEdgar (US Regulatory)Forest Laboratories Inc - Quarterly Report (10-Q)NYSE:FRXForest Road Acquisition Corp
      11/08/20078:30AMPR Newswire (US)Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data ShowNYSE:FRX
      11/02/20072:10PMPR Newswire (US)Forest Laboratories and Cypress Bioscience to Host Webcast to Discuss Clinical Data Presentations for MilnacipranNYSE:FRXForest Road Acquisition Corp
      11/01/200710:16AMPR Newswire (US)UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published iNYSE:FRXForest Road Acquisition Corp
      11/01/20078:00AMPR Newswire (US)Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the JoNYSE:FRXForest Road Acquisition Corp
      10/16/20078:05AMPR Newswire (US)Forest Laboratories Reports Earnings Per Share of $0.71 for Q2'08 Including $0.15 Charge Net of Tax for Licensing ChargeNYSE:FRXForest Road Acquisition Corp
      10/15/20074:10PMPR Newswire (US)Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for SchizophreniaNYSE:FRXForest Road Acquisition Corp
      10/12/20079:01AMPR Newswire (US)Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)NYSE:FRXForest Road Acquisition Corp
      10/08/200712:38PMPR Newswire (US)Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter EarningsNYSE:FRXForest Road Acquisition Corp
      09/18/20076:05AMPR Newswire (US)Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual CongressNYSE:FRXForest Road Acquisition Corp
      09/17/20078:03AMPR Newswire (US)Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing CollaborationNYSE:FRXForest Road Acquisition Corp
      09/05/200712:24PMPR Newswire (US)Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent DecisionNYSE:FRXForest Road Acquisition Corp
      09/04/200712:42PMPR Newswire (US)Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal ofNYSE:FRXForest Road Acquisition Corp
       Showing the most relevant articles for your search:NYSE:FRX